Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026)
Alphatec Holdings (ATEC) posted Cash from Investing Activities of -$19.9 million for Q1 2026, down 26.43% sequentially from -$15.7 million in Q4 2025, and down 71.32% YoY from -$69.4 million in Q1 2025.
Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Alphatec Holdings has reported Cash from Investing Activities for 17 years, with the latest figure at -$19.9 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 71.32% year-over-year to -$19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.7 million (up 13.27% YoY) and the FY2025 annual result came in at -$53.4 million, up 42.65% from the prior year.
- Cash from Investing Activities slipped to -$19.9 million in Q1 2026 per ATEC's latest filing, from -$15.7 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$3.7 million in Q4 2024 and troughed at -$75.6 million in Q2 2023.
- A 5-year average of -$21.6 million and a median of -$15.7 million in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities sank 424.38% in 2023, then jumped 86.72% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$14.8 million in 2022, then plunged by 90.18% to -$28.2 million in 2023, then surged by 86.72% to -$3.7 million in 2024, then plunged by 320.05% to -$15.7 million in 2025, then dropped by 26.43% to -$19.9 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$19.9 million, -$15.7 million, and -$13.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Alphatec Holdings | 1.48 Bn | 1.36 Bn | 154.10 Mn | -22.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.72 Mn |
| Jun 30, 2026 | -22.72 Mn |
| Mar 31, 2026 | -19.89 Mn |
| Mar 31, 2026 | -19.89 Mn |
| Dec 31, 2025 | -15.74 Mn |
| Dec 31, 2025 | -15.74 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Jun 30, 2025 | -12.17 Mn |
| Jun 30, 2025 | -12.17 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Sep 30, 2024 | -19.88 Mn |
| Sep 30, 2024 | -19.88 Mn |
| Jun 30, 2024 | -35.89 Mn |
| Jun 30, 2024 | -35.89 Mn |
| Mar 31, 2024 | -33.62 Mn |
| Mar 31, 2024 | -33.62 Mn |